Connect with George Kouvas
George has long experience in industrial environments where he brought complex systems to market. He is passionate about helping the community bring technical innovations to life with the goal to improve the lives of people with nervous system disorders.
George Kouvas joined the Wyss Center in February 2017 and was appointed as CTO in January 2020. With over 20 years of experience in medical devices, neurotechnology, pharma, eHealth, eBusiness and R&D services, Kouvas holds a Diploma in Electrical and Computer Engineering and an MBA, from the National Technical University of Athens (NTUA).
Under his leadership, one of the Wyss Center’s flagship programs, EPIOS™ sub-scalp brain monitoring system, evolved from an initial idea to an investable technology to be validated in clinical settings.
George enjoys reviewing and evaluating technology innovation projects and proposals.
Prior to joining the Wyss Center, he was a Director and Technical leader of Merck’s eHealth platform in Switzerland, where he managed the development and market-launch of disease management solutions for several therapeutic areas. Earlier in his career he held various engineering and management roles, coordinating consortiums of technology, business and academia partners in innovation projects.
Study contributes to our understanding of how cocaine withdrawal affects brain circuits
The results could help clinicians understand addiction and enable people to better manage substance withdrawal.Collaboration
Study suggests a promising future for soft bioelectronic interfaces in clinical settings
Results demonstrate MRI compatibility, good surgical handling and reliable recording in bioelectronic interfaces that conform to the nervous system.Technology
Shining a light on neurodegenerative disorders
Could a ray of light stop rogue proteins in their tracks and slow the spread of neurodegenerative disease in the brain? EPFL and the Wyss Center are set to find out.Collaboration